<?xml version="1.0" encoding="UTF-8"?>
<!-- generated by CLiX/Wiki2XML [MPI-Inf, MMCI@UdS] $LastChangedRevision: 92 $ on 16.04.2009 17:15:50[mciao0826] -->
<!DOCTYPE article SYSTEM "../article.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
<header>
<title>Lorenzo&apos;s oil</title>
<id>538131</id>
<revision>
<id>244311616</id>
<timestamp>2008-10-10T05:43:32Z</timestamp>
<contributor>
<username>Joy</username>
<id>20318</id>
</contributor>
</revision>
<categories>
<category>Lipids</category>
</categories>
</header>
<bdy>

For the film, see <movie wordnetid="106613686" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../180/538180.xml">
Lorenzo's Oil (film)</link></movie>
.
<b>Lorenzo's oil</b> is a 4:1 mixture of glycerol trioleate and glycerol trierucate (the <link xlink:type="simple" xlink:href="../525/56525.xml">
triglyceride</link> forms of <link xlink:type="simple" xlink:href="../100/661100.xml">
oleic</link> and <link xlink:type="simple" xlink:href="../078/302078.xml">
erucic acid</link>) used in the preventive treatment of <link xlink:type="simple" xlink:href="../952/52952.xml">
adrenoleukodystrophy</link> (ALD). The oil was formulated by <link xlink:type="simple" xlink:href="../218/5354218.xml">
Augusto and Michaela Odone</link> after their son <person wordnetid="100007846" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../311/4212311.xml">
Lorenzo</link></person>
 was diagnosed with the disease in 1984, at the age of five. Augusto received U.S. Patent No. 5,331,009 for the oil. The royalties he now receives are paid to the <link xlink:type="simple" xlink:href="../408/7137408.xml">
Myelin Project</link> which he and Michaela founded to further research treatments for ALD and similar disorders. The Odones and their invention obtained widespread publicity in 1992 because of the film <it><movie wordnetid="106613686" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../180/538180.xml">
Lorenzo's Oil</link></movie>
</it>.<p>

<person wordnetid="100007846" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../311/4212311.xml">
Lorenzo Odone</link></person>
 died on <link xlink:type="simple" xlink:href="../654/19654.xml">
May 30</link>, <link xlink:type="simple" xlink:href="../825/35825.xml">
2008</link>, after suffering from <link xlink:type="simple" xlink:href="../307/1627307.xml">
aspiration pneumonia</link>, caused by food getting stuck in his lungs.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%221%22])">1</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%222%22])">2</ref></p>

<sec>
<st>
Cost and reimbursement</st>
<p>

Lorenzo's oil costs approximately US$440 for a month's treatment. Most insurance companies will not pay for it since it is still being evaluated by the <link xlink:type="simple" xlink:href="../632/11632.xml">
FDA</link>.</p>

</sec>
<sec>
<st>
Mechanism of action</st>
<p>

This mixture of <link xlink:type="simple" xlink:href="../975/10975.xml">
fatty acid</link>s reduces the levels of very long chain fatty acids (VLCFA) known to cause <link xlink:type="simple" xlink:href="../952/52952.xml">
ALD</link>. It does so by <link xlink:type="simple" xlink:href="../189/582189.xml">
competitively inhibiting</link> the <link xlink:type="simple" xlink:href="../257/9257.xml">
enzyme</link> that forms VLCFAs.</p>

</sec>
<sec>
<st>
Effectiveness</st>

<p>

<indent level="1">

<it>Main article: <link xlink:type="simple" xlink:href="../952/52952.xml#xpointer(//*[./st=%22Treatment%22])">
Adrenoleukodystrophy#Treatment</link></it>
</indent>
Lorenzo's oil, in combination with a diet low in VLCFA, has been used with limited success, especially before disease symptoms appear. A 2005 study shows positive long-term results with this approach.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%223%22])">3</ref> A 2007 report also appraises "Lorenzo's oil".<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%224%22])">4</ref> See also <link xlink:type="simple" xlink:href="../408/7137408.xml">
the Myelin Project</link>.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%225%22])">5</ref></p>

<ss1>
<st>
Studies</st>

<p>

In an early study, Duchesne studied eight males and reported improvements in follow-up magnetic resonance imaging of the brain.</p>
<p>

In the only clinical study with positive findings, Moser tried Lorenzo's oil in 53 asymptomatic patients with ALD. Analysis of the effect of Lorenzo's oil indicated that there was only a slight but statistically significant slowing of clinical progression and delay of death.</p>
<p>

A controlled study by Moser concluded that Lorenzo's oil does not alter the course of the illness in symptomatic patients; however, dietary therapy started before the development of symptoms may reduce the frequency and severity of subsequent neurological disability. </p>
<p>

A study by Poulos found that Lorenzo's oil is of limited value in correcting the accumulation of saturated VLCFAs in the brain of patients with ALD.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%226%22])">6</ref></p>
<p>

Patrick Aubourg reported in the <it><periodical wordnetid="106593296" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../492/486492.xml">
New England Journal of Medicine</link></periodical>
</it> the results of an open trial of treatment with Lorenzo's oil in 14 men with adrenomyeloneuropathy, five symptomatic heterozygous women, and five boys (mean age, 13 years) with preclinical ALD. Over a mean follow-up of 33 months, none of the 14 men with ALD improved, one of the five asymptomatic boys developed signs of <link xlink:type="simple" xlink:href="../949/1053949.xml">
myelopathy</link>, and there were no changes in the symptomatic heterozygous women. The authors concluded that this open trial found no evidence of a clinically relevant benefit from dietary treatment with Lorenzo's oil in patients with ALD.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%227%22])">7</ref></p>
<p>

A 2005 study by Moser et al in the journal <it><work wordnetid="104599396" confidence="0.8">
<product wordnetid="104007894" confidence="0.8">
<creation wordnetid="103129123" confidence="0.8">
<artifact wordnetid="100021939" confidence="0.8">
<periodical wordnetid="106593296" confidence="0.8">
<publication wordnetid="106589574" confidence="0.8">
<link xlink:type="simple" xlink:href="../609/3433609.xml">
Archives of Neurology</link></publication>
</periodical>
</artifact>
</creation>
</product>
</work>
</it> examined the effectiveness of Lorenzo's oil and moderate fat restriction on 89 asymptomatic boys at risk for ALD. After 7 years of treatment 24% of the boys developed MRI abnormalities and 11% developed both neurological and MRI abnormalities. The study demonstrated a significant association between the development of MRI abnormalities and a plasma hexacosanoic acid increase. The researchers concluded that Lorenzo's oil therapy be given to asymptomatic boys with X-linked adrenoleukodystophy who have normal brain MRI results to delay the onset of disease <ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%228%22])">8</ref>.
Comparative autopsies showed that treatment enriched erucic acid in plasma and tissues, but not in the brain.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%229%22])">9</ref></p>

</ss1>
</sec>
<sec>
<st>
Current state</st>
<p>

In summary, although dietary manipulation using Lorenzo's oil has been shown to change blood test results, it appears to be ineffective for the symptomatic ALD even though some parents of ALD patients feel otherwise. However, studies by Dr. Hugo Moser have found evidence that use of the oil by asymptomatic patients may delay the onset of symptoms significantly.</p>
<p>

In the U.S., Lorenzo’s oil is currently only available to patients taking part in a clinical trial at the <link>
Kennedy Krieger Institute</link>.  This trial was formerly held under the direction of Dr. <link>
Hugo Moser</link>, until Moser's death in 2007.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2210%22])">10</ref> Moser's team, Dr. Gerald Raymond and Ann Moser continue the trial and his work with the leukodystrophies.</p>

</sec>
<sec>
<st>
 External links </st>
<p>

<list>
<entry level="1" type="bullet">

<weblink xlink:type="simple" xlink:href="http://www.jr2.ox.ac.uk/bandolier/booth/neurol/lorenz.html">
Lorenzo's oil for adrenoleukodystrophy and adrenomyeloneuropathy</weblink></entry>
<entry level="1" type="bullet">

<weblink xlink:type="simple" xlink:href="http://www.myelin.org/atlantajournal.htm">
<it>Lorenzo's Oil Lives Up to Its Billing</it> Atlanta Journal Constitution – July 12, 2005</weblink></entry>
<entry level="1" type="bullet">

<weblink xlink:type="simple" xlink:href="http://www.usatoday.com/news/health/2005-07-11-lorenzos-oil_x.htm">
Study: Lorenzo's Oil protects against ailment</weblink></entry>
<entry level="1" type="bullet">

<weblink xlink:type="simple" xlink:href="http://www.myelin.org">
The Myelin Project</weblink></entry>
</list>
</p>

</sec>
<sec>
<st>
References</st>

<p>

<reflist>
<entry id="1">
<weblink xlink:type="simple" xlink:href="http://news.bbc.co.uk/2/hi/americas/7429221.stm">
 Lorenzo's Oil boy is dead at 30</weblink>, BBC News; retrieved 2008-06-02.</entry>
<entry id="2">
<weblink xlink:type="simple" xlink:href="http://edition.cnn.com/2008/US/05/30/lorenzo.odone.ap/">
 Subject of 'Lorenzo's Oil' dies at 30</weblink>, CNN; retrieved 2008-07-12</entry>
<entry id="3">
 <cite style="font-style:normal">Moser, HW; Raymond GV, Lu S-E, Muenz LR, Moser AB, Xu J, Jones RO, Loes DJ, Melhem ER, Dubey P, Bezman L, Brereton NH, Odone A&#32;(2005-07).&#32;"Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo's Oil". <it>Archives of Neurology</it>&#32;<b>62</b>&#32;(7): p. 1073–80. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1001%2Farchneur.62.7.1073">
10.1001/archneur.62.7.1073</weblink>. PMID 16009761.</cite>&nbsp;</entry>
<entry id="4">
 <cite style="font-style:normal">Moser, HW; Moser AB, Hollandsworth K, Brereton NH, Raymond GV&#32;(2007-09).&#32;""Lorenzo's oil" therapy for X-linked adrenoleukodystrophy: rationale and current assessment of efficacy". <it>Journal of Molecular Neuroscience</it>&#32;<b>33</b>&#32;(1): p. 105–13. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1007%2Fs12031-007-0041-4">
10.1007/s12031-007-0041-4</weblink>. PMID 17901554.</cite>&nbsp;</entry>
<entry id="5">
Weis, Margaret&#32;(2008-05-07).&#32;"<weblink xlink:type="simple" xlink:href="http://www.myelin.org/en/art/?14">
A review of recent progress</weblink>".&#32;<it>The Myelin Project</it>.&#32;Retrieved on <link>
2008-05-31</link>.</entry>
<entry id="6">
 <cite style="font-style:normal">Poulos A, Gibson R, Sharp P, Beckman K, Grattan-Smith P&#32;(1994).&#32;"Very long chain fatty acids in X-linked adrenoleukodystrophy brain after treatment with Lorenzo's oil". <it>Ann. Neurol.</it>&#32;<b>36</b>&#32;(5): 741–6. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1002%2Fana.410360509">
10.1002/ana.410360509</weblink>. PMID 7979219. Retrieved on <link>
2007-12-10</link>.</cite>&nbsp;</entry>
<entry id="7">
 <cite style="font-style:normal">Aubourg P, Adamsbaum C, Lavallard-Rousseau MC, et al&#32;(1993).&#32;"A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy". <it>N. Engl. J. Med.</it>&#32;<b>329</b>&#32;(11): 745–52. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1056%2FNEJM199309093291101">
10.1056/NEJM199309093291101</weblink>. PMID 8350883. Retrieved on <link>
2007-12-10</link>.</cite>&nbsp;</entry>
<entry id="8">
<weblink xlink:type="simple" xlink:href="http://archneur.ama-assn.org/cgi/content/full/62/7/1073">
Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo's oil. Arch Neurol. 2005;62:1073-1080.</weblink></entry>
<entry id="9">
 <cite style="font-style:normal">Magnhild Rasmussen, Ann B. Moser, Janet Borel, Surinder Khangoora and Hugo W. Moser&#32;(Aug, 1994).&#32;"<weblink xlink:type="simple" xlink:href="http://www.springerlink.com/content/j062517w8v068541">
Brain, liver, and adipose tissue erucic and very long chain fatty acid levels in adrenoleukodystrophy patients treated with glyceryl trierucate and trioleate oils (Lorenzo's Oil)</weblink>". <it>Neurochemical Research</it>&#32;<b>19</b>: 1073–1082.&#32;Springer Netherlands. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1007%2FBF00968719">
10.1007/BF00968719</weblink>.</cite>&nbsp;</entry>
<entry id="10">
Shankar Vedantam.&#32;"<weblink xlink:type="simple" xlink:href="http://www.washingtonpost.com/wp-dyn/content/article/2007/01/27/AR2007012701542_pf.html">
A Real-Life Sequel to 'Lorenzo's Oil' - washingtonpost.com</weblink>", Washington Post
2007-01-28, pp.&nbsp;A01.&#32;Retrieved on <link>
2007-12-10</link>.&nbsp;</entry>
</reflist>
</p>


</sec>
</bdy>
</article>
